Search
for
Sort by
Research 841–870 of 1000+
- Superficial granulomatous pyoderma: A localized vegetative form of pyoderma gangrenosum
- Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases
- Alopecia areata
- Age-associated inflammation inhibits epidermal stem cell function
- Lupus erythematosus: systemic and cutaneous manifestations
- Telogen effluvium
- Protoporphyrin IX: the Good, the Bad, and the Ugly
- Hormone replacement therapy and the skin
- Somatic stem cell heterogeneity: diversity in the blood, skin and intestinal stem cell compartments
- Estrogens and the skin
- Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
- Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy
- A role of melatonin in neuroectodermal‐mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors
- Pharmacological evidences for the extracts and secondary metabolites from plants of the genus Hibiscus
- Extraskeletal actions of vitamin D
- HAIR REGROWTH
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Principles of Hair Cycle Control
- Oral retinoids-present status
- Interferon in the treatment of cutaneous T-cell lymphoma
- Ultraviolet Radiation in Wound Care: Sterilization and Stimulation
- Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies
- 9 Role of 5α-reductase in health and disease
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- Androgens and androgen receptor action in skin and hair follicles
- Thymosin β<sub>4</sub>increases hair growth by activation of hair follicle stem cells
- Beyond acne: Current aspects of sebaceous gland biology and function
- Control of hair follicle cell fate by underlying mesenchyme through a CSL–Wnt5a–FoxN1 regulatory axis
- Melanocytes: The new Black
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer